首页 > 最新文献

眼科学报最新文献

英文 中文
Is macular hole a risk factor for retinal detachment? 黄斑孔是视网膜脱离的危险因素吗?
Pub Date : 2016-04-15 DOI: 10.21037/jes.2016.04.03
H. Kim, Ji Eun Lee
There was an ‘outbreak’ of retinal detachment after macular hole (MH) surgery in early 2000s (1,2). Retinal detachment in a vitrectomized eye may result in a disaster of proliferative vitreoretinopathy, if the vitreous has not been removed sufficiently. The outbreak was associated with several factors in the era.
21世纪初,黄斑孔(MH)手术后出现了视网膜脱离的“爆发”(1,2)。如果玻璃体没有被充分切除,玻璃体切除后的视网膜脱离可能导致增殖性玻璃体视网膜病变。疫情的爆发与当时的几个因素有关。
{"title":"Is macular hole a risk factor for retinal detachment?","authors":"H. Kim, Ji Eun Lee","doi":"10.21037/jes.2016.04.03","DOIUrl":"https://doi.org/10.21037/jes.2016.04.03","url":null,"abstract":"There was an ‘outbreak’ of retinal detachment after macular hole (MH) surgery in early 2000s (1,2). Retinal detachment in a vitrectomized eye may result in a disaster of proliferative vitreoretinopathy, if the vitreous has not been removed sufficiently. The outbreak was associated with several factors in the era.","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"33 1","pages":"134-6"},"PeriodicalIF":0.0,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88552826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mesenchymal stem cell secretome to control inflammation in allergic conjunctivitis. 间充质干细胞分泌组控制过敏性结膜炎炎症。
Pub Date : 2016-04-15 DOI: 10.21037/JES.2016.04.06
M. Baiula, S. Spampinato
Su and colleagues (1) propose the use of culture medium from TNF-α pre-conditioned bone marrow-derived mesenchymal stem cells (MSC) as a novel therapeutic strategy for treating allergic conjunctivitis. MSC were exposed to TNF-α and conditioned medium was topically applied in the conjunctiva of mice with short ragweed pollen-induced experimental allergic conjunctivitis. Interestingly, ocular administration of TNF-α-conditioned medium reduced clinical signs and symptoms of allergic conjunctivitis. The anti-allergic effect of TNF-α-conditioned medium appeared to be due to the reduction of inflammatory cells infiltration and accumulation in the conjunctiva, inhibition of B cells, mast cells and histamine functions, through a COX-2-dependent mechanism. In fact, pre-treating MSC with COX-2 siRNA, the anti-allergic effects were abrogated. It seems that factors produced by MSC treated with TNF-α exert anti-allergic properties targeting simultaneously several key mediators of allergic reaction like B cells, mast cells, histamine and T helper 2 (Th2) cells.
Su及其同事(1)提出使用TNF-α预处理骨髓间充质干细胞(MSC)培养基作为治疗过敏性结膜炎的新治疗策略。将细胞间充质干细胞暴露于TNF-α,并在短豚草花粉诱导的实验性变应性结膜炎小鼠结膜局部应用条件培养基。有趣的是,眼部给药TNF-α条件培养基可减轻过敏性结膜炎的临床体征和症状。TNF-α-条件培养基的抗过敏作用可能是通过cox -2依赖机制,减少结膜内炎症细胞的浸润和积聚,抑制B细胞、肥大细胞和组胺功能。事实上,用COX-2 siRNA预处理MSC,其抗过敏作用被取消。MSC经TNF-α处理后产生的因子似乎同时针对B细胞、肥大细胞、组胺和辅助性T细胞(Th2)等几种过敏反应的关键介质发挥抗过敏特性。
{"title":"Mesenchymal stem cell secretome to control inflammation in allergic conjunctivitis.","authors":"M. Baiula, S. Spampinato","doi":"10.21037/JES.2016.04.06","DOIUrl":"https://doi.org/10.21037/JES.2016.04.06","url":null,"abstract":"Su and colleagues (1) propose the use of culture medium from TNF-α pre-conditioned bone marrow-derived mesenchymal stem cells (MSC) as a novel therapeutic strategy for treating allergic conjunctivitis. MSC were exposed to TNF-α and conditioned medium was topically applied in the conjunctiva of mice with short ragweed pollen-induced experimental allergic conjunctivitis. Interestingly, ocular administration of TNF-α-conditioned medium reduced clinical signs and symptoms of allergic conjunctivitis. The anti-allergic effect of TNF-α-conditioned medium appeared to be due to the reduction of inflammatory cells infiltration and accumulation in the conjunctiva, inhibition of B cells, mast cells and histamine functions, through a COX-2-dependent mechanism. In fact, pre-treating MSC with COX-2 siRNA, the anti-allergic effects were abrogated. It seems that factors produced by MSC treated with TNF-α exert anti-allergic properties targeting simultaneously several key mediators of allergic reaction like B cells, mast cells, histamine and T helper 2 (Th2) cells.","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"133 1","pages":"140-2"},"PeriodicalIF":0.0,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86727870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The role of outdoor activity in myopia prevention. 户外活动在近视预防中的作用。
Pub Date : 2016-04-15 DOI: 10.21037/JES.2016.04.04
L. Deng, Yi Pang
Myopia, also known as nearsightedness, is the most common vision disorder among children and young adults. In the last several decades, the prevalence of myopia has surged in East Asia. In some industrialized regions it has already reached an epidemic level (1,2). A smaller increase in the prevalence has also been observed in Western countries (2,3). The cost of visual aids or corrections put a great financial burden on individuals, families and the health care system. Myopia is not just an optical inconvenience. Early onset myopia is often accompanied with fast progression and very likely it will end up with high myopia (higher than 6.00 D myopia). High myopia poses a higher risk for developing glaucoma, retinal detachments and other vision threatening conditions. As our understanding of myopia was and is still poor, the research and development of an effective and safe tool in controlling myopia has been moving forward slowly. The current options for slowing down myopia progression include applying pharmaceutical agents such as atropine, wearing corrections with special optical design including bifocal spectacles, dual-focal contact lenses, and orthokeratology (ortho-K) (4). The most effective treatment up-to-date is 1% atropine, with well-established clinically relevant efficacy. However, the side-effect of long-term use and rebound effect after discontinuation of atropine were major concerns. Recently published results from a study conducted in Singapore clearly showed that atropine at a much lower dosage 0.01% could slow down myopia progression in children though its treatment size was smaller compared to the higher dosage levels: 1.0%, 0.5% and 0.1% (5). In addition, their results indicated that the group with 0.01% atropine had little rebound after cessation of the treatment while the other groups progressed much faster than the control group. More investigations on this promising strategy are still ongoing. Another promising option is ortho-K contact lenses. The benefit of wearing ortho-K in retarding axial elongation has been confirmed by randomized clinical trials (RCTs) (6). Prescribing contact lenses in very young children is still non-conventional due to hygiene and safety concerns. Other optical correction methods include multifocal and bifocal spectacles. Multifocal/bifocal spectacle provides minimal myopia control effect: statistically significant but without clinical significance (4). Finally, none of these intervention methods had been studied for a long period of time (>5 years) and thus their long-term effect is unknown. Unlike studies on retarding myopia progression, publications on myopia prevention methods are rarely seen in literature.
近视,也被称为近视,是儿童和年轻人中最常见的视力障碍。在过去的几十年里,近视的发病率在东亚急剧上升。在一些工业化区域,它已经达到流行病的程度(1,2)。在西方国家也观察到患病率有较小的增加(2,3)。视觉辅助或矫正的费用给个人、家庭和卫生保健系统带来了巨大的经济负担。近视不仅仅是视觉上的不便。早发性近视通常伴有快速发展,很可能最终发展为高度近视(高于6.00 D的近视)。高度近视会增加青光眼、视网膜脱离和其他视力威胁疾病的风险。由于我们对近视的认识过去和现在仍然很差,有效、安全的控制近视工具的研究和开发进展缓慢。目前减缓近视进展的选择包括使用阿托品等药物,佩戴特殊光学设计的矫正眼镜,包括双焦点眼镜、双焦点隐形眼镜和角膜塑形术(ortho-K)(4)。目前最有效的治疗方法是1%阿托品,具有良好的临床相关疗效。然而,长期使用阿托品的副作用和停药后的反弹效应是主要的问题。新加坡最近发表的一项研究结果清楚地表明,0.01%的低剂量阿托品可以减缓儿童近视的进展,尽管其治疗规模比1.0%、0.5%和0.1%的高剂量阿托品要小(5)。此外,他们的结果表明,0.01%的阿托品组在停止治疗后几乎没有反弹,而其他组的进展速度比对照组快得多。关于这一有前途的战略的更多调查仍在进行中。另一个有希望的选择是orthok隐形眼镜。随机临床试验(rct)证实了佩戴orthok在延缓轴向伸长方面的益处(6)。由于卫生和安全方面的考虑,在非常年幼的儿童中处方隐形眼镜仍然是非常规的。其他光学校正方法包括多焦点和双焦点眼镜。多焦/双焦眼镜控制近视的效果最小:具有统计学意义,但没有临床意义(4)。最后,这些干预方法都没有经过长时间(>5年)的研究,因此其长期效果尚不清楚。与延缓近视进展的研究不同,有关近视预防方法的出版物在文献中很少见到。
{"title":"The role of outdoor activity in myopia prevention.","authors":"L. Deng, Yi Pang","doi":"10.21037/JES.2016.04.04","DOIUrl":"https://doi.org/10.21037/JES.2016.04.04","url":null,"abstract":"Myopia, also known as nearsightedness, is the most common vision disorder among children and young adults. In the last several decades, the prevalence of myopia has surged in East Asia. In some industrialized regions it has already reached an epidemic level (1,2). A smaller increase in the prevalence has also been observed in Western countries (2,3). The cost of visual aids or corrections put a great financial burden on individuals, families and the health care system. Myopia is not just an optical inconvenience. Early onset myopia is often accompanied with fast progression and very likely it will end up with high myopia (higher than 6.00 D myopia). High myopia poses a higher risk for developing glaucoma, retinal detachments and other vision threatening conditions. As our understanding of myopia was and is still poor, the research and development of an effective and safe tool in controlling myopia has been moving forward slowly. The current options for slowing down myopia progression include applying pharmaceutical agents such as atropine, wearing corrections with special optical design including bifocal spectacles, dual-focal contact lenses, and orthokeratology (ortho-K) (4). The most effective treatment up-to-date is 1% atropine, with well-established clinically relevant efficacy. However, the side-effect of long-term use and rebound effect after discontinuation of atropine were major concerns. Recently published results from a study conducted in Singapore clearly showed that atropine at a much lower dosage 0.01% could slow down myopia progression in children though its treatment size was smaller compared to the higher dosage levels: 1.0%, 0.5% and 0.1% (5). In addition, their results indicated that the group with 0.01% atropine had little rebound after cessation of the treatment while the other groups progressed much faster than the control group. More investigations on this promising strategy are still ongoing. Another promising option is ortho-K contact lenses. The benefit of wearing ortho-K in retarding axial elongation has been confirmed by randomized clinical trials (RCTs) (6). Prescribing contact lenses in very young children is still non-conventional due to hygiene and safety concerns. Other optical correction methods include multifocal and bifocal spectacles. Multifocal/bifocal spectacle provides minimal myopia control effect: statistically significant but without clinical significance (4). Finally, none of these intervention methods had been studied for a long period of time (>5 years) and thus their long-term effect is unknown. Unlike studies on retarding myopia progression, publications on myopia prevention methods are rarely seen in literature.","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"92 1","pages":"137-9"},"PeriodicalIF":0.0,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83831258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Time spent outdoors and myopia: establishing an evidence base. 户外活动时间与近视:建立证据基础。
Pub Date : 2016-04-15 DOI: 10.21037/JES.2016.04.05
Enis D. Kocak, J. Sherwin
Myopia is a highly prevalent refractive error in Asia (1). Although mild myopia does not have serious ocular ramifications, pathological myopia is associated with the development of various ocular pathologies that can lead to irreversible visual loss or blindness (2). The prevalence of visual impairment attributable to pathologic myopia is 0.2-1.4% in Asian populations (3).
在亚洲,近视是一种非常普遍的屈光不正(1)。尽管轻度近视没有严重的眼部后果,但病理性近视与各种眼部病变的发展有关,这些病变可导致不可逆的视力丧失或失明(2)。在亚洲人群中,病理性近视导致的视力损害发生率为0.2-1.4%(3)。
{"title":"Time spent outdoors and myopia: establishing an evidence base.","authors":"Enis D. Kocak, J. Sherwin","doi":"10.21037/JES.2016.04.05","DOIUrl":"https://doi.org/10.21037/JES.2016.04.05","url":null,"abstract":"Myopia is a highly prevalent refractive error in Asia (1). Although mild myopia does not have serious ocular ramifications, pathological myopia is associated with the development of various ocular pathologies that can lead to irreversible visual loss or blindness (2). The prevalence of visual impairment attributable to pathologic myopia is 0.2-1.4% in Asian populations (3).","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"1 1","pages":"143-6"},"PeriodicalIF":0.0,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88136156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Time spent outdoors and myopia: establishing an evidence base. 户外活动时间与近视:建立证据基础。
Pub Date : 2015-12-01
Enis D Kocak, Justin C Sherwin
{"title":"Time spent outdoors and myopia: establishing an evidence base.","authors":"Enis D Kocak, Justin C Sherwin","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"143-6"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34509376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept. 批准的药物治疗近视脉络膜新生血管:雷尼单抗和阿非利塞普的随机对照试验综述。
Pub Date : 2015-12-01
Jia-Kang Wang, Tzu-Lun Huang, Pei-Yuan Su, Pei-Yao Chang

Myopic choroidal neovascularization (mCNV) can cause severe visual impairment in highly myopic patients. We review the randomized trials of two approved pharmacotherapy for treating mCNV, including intravitreal injections of ranibizumab and aflibercept. These two vascular endothelial growth factor (VEGF) antagonists show superior ability to improve vision and reduce macular thickness, comparing with sham injections or verteporfin photodynamic therapy (vPDT). There is no severe ocular or systemic adverse reaction reported in studies associated with ranibizumab and aflibercept for mCNV. Prompt treatment with these agents can lead to a better outcome.

近视脉络膜新生血管(mCNV)可引起高度近视患者严重的视力损害。我们回顾了两种被批准用于治疗mCNV的药物治疗的随机试验,包括玻璃体内注射雷尼单抗和阿非利塞普。与假注射或维泊芬光动力治疗(vPDT)相比,这两种血管内皮生长因子(VEGF)拮抗剂显示出更好的改善视力和减少黄斑厚度的能力。在与雷尼单抗和阿非利西普治疗mCNV相关的研究中,没有报道严重的眼部或全身不良反应。及时使用这些药物治疗可以获得更好的结果。
{"title":"Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept.","authors":"Jia-Kang Wang,&nbsp;Tzu-Lun Huang,&nbsp;Pei-Yuan Su,&nbsp;Pei-Yao Chang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Myopic choroidal neovascularization (mCNV) can cause severe visual impairment in highly myopic patients. We review the randomized trials of two approved pharmacotherapy for treating mCNV, including intravitreal injections of ranibizumab and aflibercept. These two vascular endothelial growth factor (VEGF) antagonists show superior ability to improve vision and reduce macular thickness, comparing with sham injections or verteporfin photodynamic therapy (vPDT). There is no severe ocular or systemic adverse reaction reported in studies associated with ranibizumab and aflibercept for mCNV. Prompt treatment with these agents can lead to a better outcome.</p>","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"198-200"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34510887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is macular hole a risk factor for retinal detachment? 黄斑孔是视网膜脱离的危险因素吗?
Pub Date : 2015-12-01
Hyun Woong Kim, Ji Eun Lee
{"title":"Is macular hole a risk factor for retinal detachment?","authors":"Hyun Woong Kim,&nbsp;Ji Eun Lee","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"134-6"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34509373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ophthalmic profile and systemic features of pediatric facial nerve palsy. 小儿面神经麻痹的眼部轮廓和全身特征。
Pub Date : 2015-12-01
Preeti Patil-Chhablani, Sowmya Murthy, Meenakshi Swaminathan

Background: Facial nerve palsy (FNP) occurs less frequently in children as compared to adults but most cases are secondary to an identifiable cause. These children may have a variety of ocular and systemic features associated with the palsy and need detailed ophthalmic and systemic evaluation.

Methods: This was a retrospective chart review of all the cases of FNP below the age of 16 years, presenting to a tertiary ophthalmic hospital over the period of 9 years, from January 2000 to December 2008.

Results: A total of 22 patients were included in the study. The average age at presentation was 6.08 years (range, 4 months to 16 years). Only one patient (4.54%) had bilateral FNP and 21 cases (95.45%) had unilateral FNP. Seventeen patients (77.27%) had congenital palsy and of these, five patients had a syndromic association, three had birth trauma and nine patients had idiopathic palsy. Five patients (22.72%) had an acquired palsy, of these, two had a traumatic cause and one patient each had neoplastic origin of the palsy, iatrogenic palsy after surgery for hemangioma and idiopathic palsy. Three patients had ipsilateral sixth nerve palsy, two children were diagnosed to have Moebius syndrome, one child had an ipsilateral Duane's syndrome with ipsilateral hearing loss. Corneal involvement was seen in eight patients (36.36%). Amblyopia was seen in ten patients (45.45%). Neuroimaging studies showed evidence of trauma, posterior fossa cysts, pontine gliosis and neoplasms such as a chloroma. Systemic associations included hemifacial macrosomia, oculovertebral malformations, Dandy Walker syndrome, Moebius syndrome and cerebral palsy

Conclusions: FNP in children can have a number of underlying causes, some of which may be life threatening. It can also result in serious ocular complications including corneal perforation and severe amblyopia. These children require a multifaceted approach to their care.

背景:与成人相比,面神经麻痹(FNP)在儿童中发生的频率较低,但大多数病例继发于可识别的病因。这些儿童可能有多种与麻痹相关的眼部和全身特征,需要详细的眼部和全身评估。方法:回顾性分析一家三级眼科医院2000年1月至2008年12月9年间所有16岁以下的FNP病例。结果:共纳入22例患者。平均发病年龄为6.08岁(4个月至16岁)。双侧FNP 1例(4.54%),单侧FNP 21例(95.45%)。先天性麻痹17例(77.27%),其中综合征相关性5例,出生创伤3例,特发性麻痹9例。后天性麻痹5例(22.72%),其中外伤性麻痹2例,肿瘤性麻痹1例,血管瘤术后医源性麻痹1例,特发性麻痹1例。3例患儿为同侧第六神经麻痹,2例患儿为莫比乌斯综合征,1例患儿为同侧Duane综合征伴同侧听力丧失。累及角膜8例(36.36%)。弱视10例(45.45%)。神经影像学研究显示创伤,后窝囊肿,脑桥胶质增生和肿瘤如氯瘤的证据。系统性关联包括面肌巨大儿、眼椎畸形、Dandy Walker综合征、Moebius综合征和脑瘫。结论:儿童FNP可能有许多潜在原因,其中一些可能危及生命。它还会导致严重的眼部并发症,包括角膜穿孔和严重的弱视。照顾这些孩子需要多方面的方法。
{"title":"Ophthalmic profile and systemic features of pediatric facial nerve palsy.","authors":"Preeti Patil-Chhablani,&nbsp;Sowmya Murthy,&nbsp;Meenakshi Swaminathan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Facial nerve palsy (FNP) occurs less frequently in children as compared to adults but most cases are secondary to an identifiable cause. These children may have a variety of ocular and systemic features associated with the palsy and need detailed ophthalmic and systemic evaluation.</p><p><strong>Methods: </strong>This was a retrospective chart review of all the cases of FNP below the age of 16 years, presenting to a tertiary ophthalmic hospital over the period of 9 years, from January 2000 to December 2008.</p><p><strong>Results: </strong>A total of 22 patients were included in the study. The average age at presentation was 6.08 years (range, 4 months to 16 years). Only one patient (4.54%) had bilateral FNP and 21 cases (95.45%) had unilateral FNP. Seventeen patients (77.27%) had congenital palsy and of these, five patients had a syndromic association, three had birth trauma and nine patients had idiopathic palsy. Five patients (22.72%) had an acquired palsy, of these, two had a traumatic cause and one patient each had neoplastic origin of the palsy, iatrogenic palsy after surgery for hemangioma and idiopathic palsy. Three patients had ipsilateral sixth nerve palsy, two children were diagnosed to have Moebius syndrome, one child had an ipsilateral Duane's syndrome with ipsilateral hearing loss. Corneal involvement was seen in eight patients (36.36%). Amblyopia was seen in ten patients (45.45%). Neuroimaging studies showed evidence of trauma, posterior fossa cysts, pontine gliosis and neoplasms such as a chloroma. Systemic associations included hemifacial macrosomia, oculovertebral malformations, Dandy Walker syndrome, Moebius syndrome and cerebral palsy</p><p><strong>Conclusions: </strong>FNP in children can have a number of underlying causes, some of which may be life threatening. It can also result in serious ocular complications including corneal perforation and severe amblyopia. These children require a multifaceted approach to their care.</p>","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"147-50"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34509377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of visual electrophysiology for the diagnosis and treatment of cataracts. 视觉电生理在白内障诊治中的应用。
Pub Date : 2015-12-01
Duoru Lin, Jingjing Chen, Haotian Lin, Weirong Chen

Visual electrophysiology is widely used in clinical ophthalmology. It is also of significant value in the objective assessment of visual function in adult and pediatric cataract patients and for the diagnosis of and research on retinal and visual pathway diseases. This article systematically reviews visual electrophysiology techniques, their applications in the diagnosis and treatment of adult and pediatric cataracts, and factors influencing the application of visual electrophysiology during surgical treatment for cataracts.

视电生理学在眼科临床中应用广泛。对于客观评价成人和儿童白内障患者的视功能,以及视网膜和视通路疾病的诊断和研究也具有重要的价值。本文系统综述了视电生理技术及其在成人和儿童白内障诊治中的应用,以及影响视电生理技术在白内障手术治疗中的应用的因素。
{"title":"Application of visual electrophysiology for the diagnosis and treatment of cataracts.","authors":"Duoru Lin,&nbsp;Jingjing Chen,&nbsp;Haotian Lin,&nbsp;Weirong Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Visual electrophysiology is widely used in clinical ophthalmology. It is also of significant value in the objective assessment of visual function in adult and pediatric cataract patients and for the diagnosis of and research on retinal and visual pathway diseases. This article systematically reviews visual electrophysiology techniques, their applications in the diagnosis and treatment of adult and pediatric cataracts, and factors influencing the application of visual electrophysiology during surgical treatment for cataracts.</p>","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"190-7"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34510886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eye Science is transferred to AME Publishing Company to be in charge of its publication. 《眼科学》由AME出版公司负责出版。
Pub Date : 2015-12-01
Molly J Wang
{"title":"Eye Science is transferred to AME Publishing Company to be in charge of its publication.","authors":"Molly J Wang","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":12096,"journal":{"name":"Eye science","volume":"30 4","pages":"131"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34574373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
眼科学报
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1